Apyx Medical Corp Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross
Apyx Medical Corp (APYX) reported Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross of $1.30 million for the 12-month period ending 2013-12-31, per its 10-K/A filed 2014-05-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross · last filed 2014-05-08
- Apyx Medical Corp research and development arrangement, contract to perform for others, costs incurred, gross for fiscal 2013 was $1.30M, a 0.00% change from fiscal 2012.
- Apyx Medical Corp research and development arrangement, contract to perform for others, costs incurred, gross for fiscal 2012 was $1.30M, a 8.33% increase from fiscal 2011.
- Apyx Medical Corp research and development arrangement, contract to perform for others, costs incurred, gross for fiscal 2011 was $1.20M.
| Period end | Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross 12 month |
|---|---|
| 2013-12-31 | $1.30M 10-K/A · filed 2014-05-08 |
| 2012-12-31 | $1.30M 10-K/A · filed 2014-05-08 |
| 2011-12-31 | $1.20M 10-K/A · filed 2014-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |